Bank of Montreal
INZY

Bank of Montreal’s Inozyme Pharma INZY Stock Holding History

Bank of Montreal’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,297
Closed -$9.37K – 3633
2025
Q1 		$9.37K Buy
+10,297
New +$14.3K ﹤0.01% 3309
2024
Q1 		– Sell
-21,900
Closed -$99.2K – 4107
2023
Q4 		$99.2K Buy
+21,900
New +$77.8K ﹤0.01% 3379
2021
Q2 		– Sell
-388
Closed -$7K – 4268
2021
Q1 		$7K Sell
388
-877
-69% -$19.4K ﹤0.01% 4519
2020
Q4 		$33K Buy
1,265
+890
+237% +$21.2K ﹤0.01% 4161
2020
Q3 		$8K Buy
+375
New +$9.31K ﹤0.01% 4226

Other funds holding INZY

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Bank of Montreal's INZY Position: Q2 2025 in Review

Bank of Montreal sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 10,297 shares — an estimated $9.37K sold.

Bank of Montreal first reported a position in INZY in Q3 2020 and held it in 5 quarters. The position peaked at $99.2K in Q4 2023. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • Bank of Montreal reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • Bank of Montreal sold 10,297 Inozyme Pharma shares in Q2 2025, an estimated $9.37K.
  • Bank of Montreal first reported a position in Inozyme Pharma in Q3 2020 and held it in 5 quarters.
  • Bank of Montreal's Inozyme Pharma position peaked at $99.2K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.